News - 13 Mar `24Lessons In Marketing: How To Sell A Disease To Big Pharma

New

Lessons In Marketing: How To Sell A Disease To Big Pharma

Seeing Incyte’s “See What’s Possible” campaign — complete with larger-than-life vitiligo models at the AAD meeting in San Diego — was a milestone for our community.

For years, vitiligo flew below the healthcare industry’s radar. Today, it’s front-and-center: the first FDA-approved therapy is on the market, and more than 40 companies are investing in vitiligo R&D.

That momentum didn’t appear by chance; it grew from steady advocacy, data-driven storytelling, and a lot of patient and caregiver voices refusing to be invisible.

It’s proof that even a small non-profit like VRF can help shift perceptions and priorities across an entire field. We’re even considering a white paper on the journey, with the working title “How to Bring an Overlooked Disease to Pharma’s Attention.”

If you’d like to contribute insights or client-side perspectives, let us know!

— Yan Valle

CEO, Vitiligo Research Foundation | Author, A No-Nonsense Guide to Vitiligo

Vitiligo marketing

AAD, 2024

AAD, 2025

 



      FAQOther Questions

      • Can Ayurveda help with vitiligo?

        Ayurveda, the ancient Indian system of holistic medicine, focuses on balancing body energies (Doshas) and improving digestion. While it offers a valuable perspective on "whole-b...

      • What is the best therapy for localized vitiligo?

        Localized vitiligo, where the white patches are limited to one or a few areas of the body, can be managed with a few treatment approaches. The best therapy usually depends on th...

      • Can Ginkgo Biloba help with vitiligo?

        Ginkgo Biloba offers a promising, simple, and relatively affordable option for managing vitiligo. Known for its anti-inflammatory, immunomodulatory, and antioxidant properties, ...